These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 227624)
1. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)]. Loeper J; Goy-Loeper J; Rouffy J Clin Chim Acta; 1979 Oct; 98(1-2):19-26. PubMed ID: 227624 [TBL] [Abstract][Full Text] [Related]
2. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia. Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951 [TBL] [Abstract][Full Text] [Related]
3. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals]. Hutt V; Klör HU; Wechsler JG; Ditschuneit H J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054 [TBL] [Abstract][Full Text] [Related]
4. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797 [TBL] [Abstract][Full Text] [Related]
5. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)]. Jaillard J; Sezille G; Dewailly P; Fruchart JC Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484 [TBL] [Abstract][Full Text] [Related]
6. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices]. Herrmann W; Reuter W Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524 [No Abstract] [Full Text] [Related]
7. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558 [TBL] [Abstract][Full Text] [Related]
8. Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia. Gavish D; Oschry Y; Fainaru M; Eisenberg S Eur J Clin Invest; 1986 Feb; 16(1):61-8. PubMed ID: 3084275 [TBL] [Abstract][Full Text] [Related]
9. Studies on the phenotyping system of hyperlipoproteinemias. Evaluation of a new method by enzymic staining of lipids in serum lipoproteins separated by electrophoresis on agarose. Ohno F; Suehiro T; Uga S; Kawada M; Takamatsu K; Yasuoka N; Yamano T Jpn J Med; 1983 Aug; 22(3):200-5. PubMed ID: 6620708 [TBL] [Abstract][Full Text] [Related]
10. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias. Canzler H; Bojanovski D Artery; 1980; 8(2):171-8. PubMed ID: 7458684 [TBL] [Abstract][Full Text] [Related]
11. Serum lipoprotein composition in different types of hyperlipoproteinemia. Carlson LA Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148 [TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein spectrum and makeup of the individual classes in coronary arteriosclerosis with a varying lipid level in the blood plasma]. Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaia TI; Gadzhalova SI Kardiologiia; 1980 May; 20(5):42-6. PubMed ID: 7392382 [No Abstract] [Full Text] [Related]
13. Lipid composition of serum lipoproteins in patients with primary type IIb and type IV hyperlipoproteinemia. Weisweiler P; Schwandt P Atherosclerosis; 1978 Sep; 31(1):53-8. PubMed ID: 213086 [TBL] [Abstract][Full Text] [Related]
14. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV]. Romics L; Karádi I; Simonyi E Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011 [No Abstract] [Full Text] [Related]
15. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV]. Bednarska-Makaruk M; Kuźmińska A; Chotkowska E; Kurjata P; Polakowska M; Broda G; Rywik S Pol Arch Med Wewn; 1992 Mar; 87(3):149-56. PubMed ID: 1523145 [TBL] [Abstract][Full Text] [Related]
16. Effects of nicotinic acid therapy on high-density lipoprotein metabolism in type II and type IV hyperlipoproteinaemia. Packard CJ; Stewart JM; Third JL; Morgan HG; Lawrie TD; Shepherd J Biochim Biophys Acta; 1980 Apr; 618(1):53-62. PubMed ID: 6990991 [No Abstract] [Full Text] [Related]
17. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population. Jones GJ; Hewitt D; Godin GJ; Breckenridge WC; Bird J; Mishkel MA; Steiner G; Little JA Can Med Assoc J; 1980 Jan; 122(1):37-8, 40-6. PubMed ID: 7363194 [TBL] [Abstract][Full Text] [Related]
18. Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia. Agheli N; Cloarec M; Jacotot B Ann Nutr Metab; 1991; 35(5):261-73. PubMed ID: 1776822 [TBL] [Abstract][Full Text] [Related]
19. Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia. Olsson AG; Orö L Atherosclerosis; 1982 Apr; 42(2-3):229-43. PubMed ID: 6951582 [TBL] [Abstract][Full Text] [Related]
20. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)]. Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]